[ad_1]
The current ratio of AngioDynamics, Inc. (NasdaqGS: ANGO) is 2.88. The current ratio is used by investors to determine whether a company can pay short-term and long-term debt. The current ratio is for all liquid and non-liquid badets relative to total current liabilities of the Company. A high capital ratio indicates that the company has little difficulty managing its working capital. A low liquidity ratio (when short-term liabilities are higher than current badets) indicates that the company may have difficulty paying its short-term obligations.
Investors always strive to make better decisions. There are so many options available, and this can make things more complex. Starting with a solid approach can help ease the initial incursion of the investor into the stock market. Accumulating market knowledge can take a lot of time and effort. Many investors can discover the hard way that there is no easy way to beat the markets. Many investors are teased with investment tips from friends or co – workers. It can be very tempting to take advice from someone who has already proven himself by beating the market. However, the old saying remains the same; past results may not indicate future results. Investors may find that doing their own research can provide a huge boost to the portfolio's performance.
Volatility & Price
Market volatility is a percentage that indicates whether a stock is a desirable purchase. Investors are looking at Volatility 12m to determine whether a company has a low percentage of volatility or not during a year. The 12m volatility of AngioDynamics, Inc. (NasdaqGS: ANGO) is 22.8181. This is calculated by taking the weekly normal log yields and the standard deviation of the price of the stock over an annualized year. The lower the number, the lower the volatility. Volatility 3m is a similar percentage determined by the daily normal daily yields and the standard deviation of the price of the stock over 3 months. The 3m volatility of AngioDynamics, Inc. (NasdaqGS: ANGO) is 19.3547. The 6m volatility is the same except measured over a six month period. Volatility 6m is 23.2396
We can now take a look at some historical data from the stock index. AngioDynamics, Inc. (NasdaqGS: ANGO) currently has a 10-month price index of 1.26433. The price index is calculated by dividing the current price of the stock by the stock price ten months ago. A ratio greater than one indicates an increase in the stock price during the period. A ratio below one shows that the price has decreased during this period. Looking at other periods, the 12-month price index is 1.32801, the 24-month is 1.60624, and the 36-month is 1.2869. Getting closer a bit, the 5 month price index is 1.31589, the 3 month month is 1.29616 and the month of 1.07669.
The leverage ratio of AngioDynamics, Inc. (NasdaqGS: ANGO) is 0.133309. Leverage ratio is the total debt of a company divided by the total badets of the current year and the past year divided by two. Companies are indebted to finance their daily operations. The leverage ratio can measure a company's share of capital that comes from debt. With this ratio, investors can better estimate the ability of a company to pay its financial obligations in the long and short term.
C-Score
AngioDynamics, Inc. (NasdaqGS: ANGO) currently has a Montier C-score of 1. This indicator was developed by James Montier in order to identify companies that Cooked books to better appear on paper. The score ranges from zero to six where a 0 would indicate no proof of book firing, and a 6 would indicate a high probability. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six entries in the calculation. These data included a growing difference between net income and cash flow from operations, the increase in debtor days, higher inventory sales, the increase in other current badets, the decline in the depreciation in relation to gross property, plant and equipment. F Score, ERP5 and Magic Formula
The Piotroski F-Score is a rating system between 1 and 9 that determines the financial strength of a company. The score helps to determine if the stock of a company is valuable or not. The Piotroski F score of AngioDynamics, Inc. (NasdaqGS: ANGO) is 8. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated based on the return on badets (ROA), the return on liquid badets (CFROA), the change in return on badets and the quality of profits. It is also calculated based on the evolution of the debt ratio or the leverage effect, the liquidity and the variation of the shares outstanding. The score is also determined by the change in the gross margin and the change in the turnover of the badets.
Rank ERP5 is an investment tool that badysts use to discover undervalued companies. The ERP5 focuses on the price-to-book ratio, the return on earnings, the ROCE and the average ROCE over five years. The ERP5 of AngioDynamics, Inc. (NasdaqGS: ANGO) is 5488. The lower the ERP5 rank, the more the company is undervalued. The MF ranking (aka magic formula) is a formula that identifies a valuable company at a good price. The formula is calculated by looking at companies that have a high return on income as well as a high return on investment. The MF rating of AngioDynamics, Inc. (NasdaqGS: ANGO) is 6744. A company with a low rank is considered a good company in which to invest. The magic formula was introduced in a book written by Joel Greenblatt, entitled "The Little Book That Beats the Market."
Shareholder Return
The Qi The Value of AngioDynamics , Inc. (NasdaqGS: ANGO) is 43. The Qi Value is a useful tool in determining whether a business is undervalued or not Qi The value is calculated using the following key figures: Return on EBITDA , Profit return, Return on FCF and Liquidity.The lower the Qi value, the more the company is undervalued.Value Composite One (VC1) is a method that investors use to determine the value of the badet. The VC1 of AngioDynamics, Inc. (NasdaqGS: ANGO) is 48. A company with a value of 0 is considered an undervalued company, while a company with a value of 100 is considered to be an overvalued enterprise, the VC1 is calculated using the price at book value, selling price, EBITDA to EV, cash flow price, and price to profit. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Return. The Value Composite Two of AngioDynamics, Inc. (NasdaqGS: ANGO) is 53 years old.
Source link
